I remember.....We almost went belly up trying to bring one of them to the market.....we had to sell ( give ) our rights to Thal's analogs to stay alive. However...I would not be surprised if we find out towards the end of one of Celgene's 4th Quarters that Doc Holaday cut a better deal for the analogs than we are aware of......like maybe 5% after 300 million annual revs......after all after that deal with Celgene, Doc Holaday was forced out.....now why would Celgene be upset with Holaday after he handed them such a sweet deal....there must be a kicker in that deal that we are unaware of. Best Regards.
Market Data 
Markets 
AI
